Ralph Levitt
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- James E. Krook (11 shared papers)Loren K. Tschetter (14 shared papers)J A Mailliard (7 shared papers)James B. Gerstner (7 shared papers)Jeff A. Sloan (15 shared papers)Steven R. Alberts (5 shared papers)Carl G. Kardinal (3 shared papers)Harry S. Wieand (4 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer (10 papers)Journal of Neuro-Oncology (4 papers)Lung Cancer (4 papers)Nicotine & Tobacco Research (2 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Ralph Levitt
67 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 109
- Oncology 1.8k
- Hepatology 380
- Genetics 526
- Internal Medicine 110
- Hematology 339
Countries citing papers authored by Ralph Levitt
This map shows the geographic impact of Ralph Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Levitt more than expected).
Fields of papers citing papers by Ralph Levitt
This network shows the impact of papers produced by Ralph Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Levitt. The network helps show where Ralph Levitt may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralph Levitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 399 | |
| 2 | 1991 | 318 | |
| 3 | 1994 | 257 | |
| 4 | 1997 | 226 | |
| 5 | 2003 | 199 | |
| 6 | 2004 | 169 | |
| 7 | 1999 | 163 | |
| 8 | 2002 | 147 | |
| 9 | 1997 | 141 | |
| 10 | 1999 | 137 | |
| 11 | 2006 | 134 | |
| 12 | 2004 | 103 | |
| 13 | 1994 | 102 | |
| 14 | 2002 | 97 | |
| 15 | 2006 | 95 | |
| 16 | 1991 | 91 | |
| 17 | 2002 | 68 | |
| 18 | 2001 | 67 | |
| 19 | 2005 | 66 | |
| 20 | 2000 | 66 |
About Ralph Levitt
Ralph Levitt is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 67 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Glioma Diagnosis and Treatment (8 papers), HER2/EGFR in Cancer Research (7 papers), Lung Cancer Research Studies (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Oncology (1.8k citations), Hepatology (380 citations), Genetics (526 citations), Internal Medicine (110 citations) and Hematology (339 citations). Ralph Levitt has collaborated with scholars based in United States, India and Canada. Frequent co-authors include James E. Krook, Loren K. Tschetter, J A Mailliard, James B. Gerstner, Jeff A. Sloan, Steven R. Alberts, Carl G. Kardinal, Harry S. Wieand, Richard M. Goldberg and Kendrith M. Rowland. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Journal of Neuro-Oncology, Lung Cancer and Nicotine & Tobacco Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.